…risk of these cancers (e.g., people with a BRCA alteration or family history).” Study: Cervical Cells and Ovarian Cancer Risk Prediction A new study suggests that cell samples that are routinely collected…
…this new study, working with a range of ovarian cancer cells, with and without BRCA mutations, researchers found that PGCCs appeared more often in all tumors that were resistant to…
…serous or was related to a BRCA gene mutation, or change, received either olaparib by itself or olaparib plus cediranib. Researchers found that 80% of the women who received the…
…for the laymen and women: our bodies have genes whose jobs are to keep our cells from becoming cancerous tumors. Sometimes these genes become mutated, such as the BRCA mutation,…
…of the disease, or with BRCA1/2 genetic mutations. The complete recommendation was published in JAMA, with several accompanying editorials in related publications by experts in the field who offer their…
…some patients, especially those with BRCA mutations. In 2020, PARP inhibitors received FDA approval as first-line therapy for a subset of patients with advanced ovarian cancers, and has been shown to…
…reported higher rates of clinically actionable multigene panel results in Ashkenazi Jewish patients, suggesting that panel testing should be offered to Ashkenazi Jewish patients who test negative for BRCA1/2. Andrew…
…risk-reducing surgeries or using chemoprevention. Furthermore, women with ovarian cancer caused by BRCA mutations might be eligible for new personalized therapies. 124 30 Affordable Care Act Update Read a statement…
…Cancer Research Center, and the Director of Gynecologic Oncology Research at the Basser Center for BRCA. A highly accomplished basic science researcher, the Prize recognizes his previous and ongoing research…
…potential precancerous sites in healthy fallopian tissue of postmenopausal BRCA1 mutation carriers, researchers found that further study is needed to determine whether these changes are evidence of the earliest stages…
…on the role of the BRCA-Fanconi anemia pathway. She has been exploring how a better understanding of this pathway can lead to more effective therapies and prevention of ovarian cancers….
…Gong of Cleveland Clinic has been awarded the Liz Tilberis Research Prize for Outstanding Early Career Investigators for his work to advance knowledge of BRCA-mutant ovarian cancer. Learn more. New…
Get email updates about research news, action alerts, and ways to join the fight.
